(MGRC) is making its genetic screening tests available in Indonesia via a partnership with medical and pharmaceutical distributor Medifirst Sdn Bhd.In a Friday statement, it said the genetic screening tests will be made available through Medifirst's extensive network of primary care physicians and specialists in hospitals and medical centres, among others.
According to Medifirst director Datuk Yap Kon Min, Indonesia has over 2,000 hospitals and 9,000 community and general practitioner clinics, most of which are privately owned.
"We already have over 100 doctors waiting to be able to use Malaysian Genomics’ genetic screening tests to help patients make better informed decisions to safeguard their health,” he added.
Malaysian Genomics began the development of genetic screening tests for doctors in 2012 and has built the capacity to provide genetic insights into hundreds of diseases and traits that generate actionable information and new knowledge in personalised, preventive healthcare.
"We will work closely with Medifirst to ensure the delivery of our genetic screening tests through the proper professional healthcare channels across Indonesia.
"By identifying possible health risks from the genetic screening results, patients can plan with their doctor on ways to mitigate the risk of diseases occurring using available prevention, monitoring and treatment options," said MGRC CEO Sasha Nordin.